We used transgenic mice expressing a dominant negative mutation of interleukin-113 converting enzyme (ICE) (C285G) in a model of transient focal ischemia in order to investigate the role of ICE in ischemic brain damage, Trans genic mutan { ICE mice (n = 11) and wild-type littermates (n = 9) were subjected to 3 h of middle cerebral artery occlusion followed by 24 h of reperfusion. Cerebral infarcts and brain swelling were reduced by 44% and 46%, respectively. Neuro logical deficits were also significantly reduced. Regional CBF, blood pressure, core temperature, and heart rate did not differ between groups when measured for up to I h after reperfusion.
Summary: We used transgenic mice expressing a dominant negative mutation of interleukin-113 converting enzyme (ICE) (C285G) in a model of transient focal ischemia in order to investigate the role of ICE in ischemic brain damage, Trans genic mutan { ICE mice (n = 11) and wild-type littermates (n = 9) were subjected to 3 h of middle cerebral artery occlusion followed by 24 h of reperfusion. Cerebral infarcts and brain swelling were reduced by 44% and 46%, respectively. Neuro logical deficits were also significantly reduced. Regional CBF, blood pressure, core temperature, and heart rate did not differ between groups when measured for up to I h after reperfusion.
Apoptosis is a cell suicide program that involves a complex cascade of caspases. The interleukin-113 con verting enzyme (ICE) family caspases (Alnemri et aI., 1996) are the human homologues of the nematode C. elegans Ced-3 (Ellis et aI., 1991; Yuan and Horvitz, 1990) . Apoptosis occurs in mammalian cells either physiologically during development (Raff et al. 1993) , during degenerative neurological diseases (Thompson, 1995) , or after acute tissue insults such as ischemia (Li et aI., 1995a; Charriaut-Marlangue et aI., 1996) and trau matic injury (Rink et aI., 1995) . Inhibition of ICE and Increases in immunoreactive IL-113 levels, observed in isch emic wild-type brain at 30 min after reperfusion, were 77% lower in the mutant strain, indicating that proIL-ll3 cleavage is inhibited in the mutants. DNA fragmentation was reduced in the mutants 6 and 24 h after reperfusion. Hence, endogenous expression of an ICE inhibitor confers resistance to cerebral ischemia and brain swelling. Our results indicate that down regulation of ICE expression might provide a useful therapeutic target in cerebral ischemia. Key Words: DNA fragmentation infarction-interleukin-113 converting enzyme-mutant mice-neurological deficit-transient focal ischemia. (Hara et aI., 1997) or rats (Loddick et aI., 1996) after intracerebroventricular injection. It has also been re ported that in a rat middle cerebral artery (MCA) occlu sion model, the administration of the IL-113 receptor an tagonist or the IL-l blocker zinc protoporphyrin, de creased water content and infarct volume in ischemic brain (Relton and Rothwell, 1992; Yamasaki et a!., 1995) .
ICE-like caspases decreases infarct volume in mice
Interleukin-113 converting enzyme is one of 10 iden tified caspase family members that share in common a QACRG consensus sequence at the active site (Alnemri et aI., 1996) . On activation, ICE is cleaved from a 45 kDa protein to a 20 and 10 kDa fragment. The active ICE enzyme is a tetramer comprised of 2 homodimers (p20-plO) (Wilson et aI., 1994; Walker et aI., 1994) . Interleu kin-l 13 converting enzyme cleaves a 31 kDa proIL-113 protein to generate mature 17.5 kDa IL-II3. IL-113 has been associated with various inflammatory reactions (Di narello, 1994) , with hypoxia-mediated apoptosis in vitro (Friedlander et al., 1996) , with global cerebral ischemia in gerbils (Saito et al., 1996) , and focal cerebral ischemia in rats in vivo (Liu et al., 1993) . Additional substrates of ICE have been recognized including pro-ICE and CPP-32 (Nichols en et al., 1995; Patel et al., 1996) .
Because inflammation and apoptosis have been iden tified as important components of transient focal isch emia (Johnson et al., 1995) , studies were undertaken to examine tissue injury in a transgenic mouse expressing a mutant ICE protein that acts as a dominant negative in hibitor of endogenous ICE . The transgene encodes for a mutant ICE protein in which the amino acid glycine has been substituted for a cysteine at the active cleavage site (position 285). In brief, this transgenic mouse develops normally but expresses a fused mutant ICE-lacZ gene under control of the neuron specific enolase promoter (NSE-M17Z). The gross ap pearance of its central nervous system and supplying blood vessels are normal. Developmental apoptosis is apparently not inhibited, as evidenced by equal numbers of neurons in the facial motor nucleus compared with wild-type littermates, although mutant dorsal root gan glia neurons are resistant to apoptosis induced by trophic factor withdrawal . In response to lipopolysaccharide challenge, brain IL-l � levels do not increase. Wf<; now report that these mutant mice de velop smaller infarcts, less neurological deficits, reduced edema, smaller IL-l � levels, and decreased DNA frag mentation after transient MCA occlusion.
MATERIALS AND METHODS

ICE mutant mice
Generation and characterization of the mutant ICEC 2 85G transgenic mouse have been reported elsewhere (Friedlander et aI., 1997) . Genetic background of the transgenic mice were SV-129 and C571B1ack6 strains. Adult mutant mice and their wild-type littermates (male and female, 19-23 g) were initially anesthetized with 1.0% and maintained on 0.4--0.8% halothane in 70% N 2 0 and 30% O 2 using a Fluotec 3 vaporizer (Colonial Medical, Amherst, NH, U.S.A.). Regional CBF, blood pres sure, heart rate, and core temperature were monitored as de scribed in Hara et aI., 1996b. For regional cerebral blood flow measurement, the tip of the laser Doppler probe was placed 2 mm posterior and 6mm lateral from bregma over the MCA perfusion area. Tempora\is muscle temperature was also main tained at approximately 36.5°C using a thermostat (BAT-12, Physitemp, Clifton, NJ, U.S.A.).
Ischemia
Filament occlusion of the left MCA was performed as de scribed previously (Hara et aI., 1996b) . Three hours after isch emia, animals were briefly reanesthetized with halothane, and the filament withdrawn. Twenty-four hours after reperfusion, the forebrains were divided into five coronal (2-mm) sections using a mouse brain matrix (RBM-2000C, Activational Sys tems, MI, U.S.A.), stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC, Sigma, St. Louis, MO, U.S.A.). The infarcted areas were quantitated by an investigator naive to the groups identity using an image-analysis system (Bioquant IV, R&M Biometrics, Inc., Nashville, TN, U.S.A.) and calculated by summing the volumes of each section determined directly (Huang et aI., 1994) , or indirectly by the following formula: contralateral hemisphere (mm3)-ipsilateral undamaged vol ume (mm3) (Swanson et aI., 1990) . Brain swelling was calcu lated according to the following formula: (infarct volume + ipsilateral undamaged volume-contralateral volume) x 100/ contralateral volume (%).
Neurological deficit
Mice were tested for neurological deficits and scored as de scribed by Bederson et al. (1986) for rats and modified by Hara et al. (1996b) for mice: 0, no observable neurological deficits (normal); I, failure to extend right forepaw (mild); 2, circling to the contralateral side (moderate); 3, loss of walking or righting reflex (severe). The rater was naive to the treatment group and assessments were made 10 min and 3 h after onset of ischemia, and again at 24 h after reperfusion.
IL-IJ3 assay
To examine for the presence of brain IL-li31evels after MCA occlusion in wild-type and mutant mice, IL-l i3 immunoreac tivity was determined using an enzyme-linked immunosorbent assay kit (Genzyme [Lot B6499Fl. Cambridge, MA, U.S.A.). Interleukin-l i3 converting enzyme mutant and wild-type litter mates (female, 18-23 g) were subjected to 2 h of MCA occlu sion followed by 30 min of reperfusion. Each hemisphere was homogenized for 15 s in phosphate buffered saline (0.1 M, pH 7.4, 4°C) containing 2 mM phenylmethyl-sulfonylfluoride (stock dissolved in dimethylsulfoxide, diluted 1: 100 in phos phate buffered saline), 1 fLg/ml leupeptin, 1 fLg/ml antipain, 1 fLg/ml aprotinin, 1 fLg/ml pepstatin, 0.05% (weight-to-volume ratio) sodium azide, and 4 mM ethylenediaminetetraacetic acid. The homogenates were centrifuged (30 min at 50,000 x g) and 100 fLI of the supernatant was used for each determination. Immunoreactive IL-l i3 data were expressed as the difference between ischemic and contralateral hemispheres.
DNA fragmentation
For analysis of DNA damage, tissue samples from the isch emic tissue and homologous contralateral hemisphere were ob tained 6 h and 24 h after 2 h of transient ischemia. DNA was isolated (Puregene Systems, Minneapolis, MN, U.S.A.), di gested with DNAse-free RNAse (Boehringer Mannheim, In dianapolis, MN, U.S.A.) and then extracted with phenol chloroform. The DNA was reprecipitated in ethanol, pelleted, and resuspended. The DNA concentration was quantitated by absorbance at 260 nm. For quantitation of DNA damage, a C 2 p]ddATP end-labeling method was used (Tilly and Hsueh, 1993; MacManus et aI., 1995) . Three fLg of DNA pooled from three animals per group were used in the labeling procedure. As internal standard 35 ng of a randomly synthesized 100 bp DNA fragment was labeled together with the sample DNA. The DNA was electrophoresed on a 2.0% agarose gel (agarose 3: 1, Am resco, Solon, OH, U.S.A.) and detected by autoradiography together with a radioactive standard. The autoradiographs were analyzed by an image analysis system (M4, Imaging Research, St. Catherines, Ontario, Canada). DNA fragmentation was measured as the intensity of the labeled DNA with a size less than than 10 kb.
Statistical analysis
Data are presented as mean ± S.D. Statistical comparisons were made by Student's t-test, two-way analysis of variance (ANOVA) followed by Student's t-tests, or by Mann-Whitney U-test as specified in the results section using the software super ANOV A or StatView 4.5 (Abacus Concepts, Berkeley, CA, U.S.A.). p < 0.05 was considered statistically significant.
RESULTS
Regional CBF decreased to approximately 20% of baseline immediately after MCA occlusion and sustained during 3 h of ischemia. After reperfusion, regional cere bral blood flow immediately increased to 80-100% of baseline. There were no significant blood flow differ ences between groups at any time point (data not shown), nor were there differences in mean arterial blood pres sure, heart rate, rectal and temporalis muscle tempera ture, blood pH, and blood gases (p02 and pC02) detected between groups (Table 1) .
Infarct volume was significantly smaller in the mutant mice using either a direct or indirect method for analysis after TTC staining (p < 0.01; Student's t-test; Fig. lA) . Infarct areas were smaller in 4 of the 5 coronal sections (4-10 mm) in the mutant group ( Fig. lB ; p < 0.05; Stu dent's t-test). Brain swelling was also diminished in the mutant mouse brain after 24 h. Whereas swelling ac counted for 9.5 ± 5.4% of the hemispheric volume in the mutant group, it was 17.9 ± 6.8% in the wild-type litter mates (p < 0.05; Student's t-test). Neurological deficits were also reduced both after 3 h ischemia and 24 h after reperfusion 'f2.3 ± 0.5 [wild type, n = 9] versus 1.5 ± 0.9 [mutant, n = 11] after 3 h ischemia, p < 0.05, Mann Whitney U-test; 1.8 ± 0.3 [wild type, n = 9] versus 0.8 ± 1.0 [mutant, n = 11] 24 h after reperfusion, p < 0.05, Mann-Whitney U-test). Mutant animals showed less turning behavior, posturing and paralysis but more spon taneous motoric activity.
Brain IL-113 level differences, which increased after 2 h ischemia and 30 min reperfusion in ischemic tissue in wild-type littermates, were 77% less in mutant mice (88.3 ± 68.0 pg/g brain [wild-type, n = 7] versus 20.6 ± 43.1 pg/g brain [mutant, n = 7], p < 0.05, Student's t-test; absolute concentrations 233 ± 156 and 246 ± 168 pg/g brain in contralateral hemisphere in wild-type lit termates and mutant mice, respectively), There were no significant differences between hemispheres in sham ani mals or in control groups. Total DNA fragmentation was measured 6 h (earliest observation of laddering in wild-type) and 24 h after 2 h ischemia ( Fig. 2A) . DNA damage was higher after 24 h than after 6 h. At 6 h ICE mutant mice showed 50% less DNA fragmentation than the wild-type littermates (total DNA damage 2055 ± 43 !-LCi/ml x b and 1036 ± 429 !-LCi/ml x b, respectively; n = 3 per group in duplicate; Student's t-test). After 24 h, total DNA damage was 47% lower in the mutant group (total DNA damage 6313 ± 96 �Ci/ml x b and 3372 ± 195 �Cilml x b, respectively; n = 3 per group in duplicate; Student's t-test). DNA lad dering was observed at 6 h in only the wild-type litter mates but not in the mutant animals whereas at 24 h it was found in all animals.
DISCUSSION
In this study we report that infarct damage after re versible MCA occlusion was attenuated by 45% in trans genic mice expressing a mutant form of ICE that inhibits the endogenous enzyme(s) (Fig. 1 ). Both infarct volume and brain swelling were reduced in the mutant mice, thereby suggesting that ICE family members (directly or indirectly) impair neuronal function after stroke, and that blocking ICE activation as well as IL-l (3 production may be useful to treat cerebral ischemia. Neurological deficits improved as well which may be in part caused by de creased brain swelling. The data seem to be consistent with recent reports showing that neuroprotection follows the administration of competitive irreversible peptide ICE inhibitors (i.e., YV AD.CMK, z-V AD.FMK and z DEVD.FMK), and this effect sustains for at least 3 days after z-V AD.FMK treatment (Hara et aI., 1997) . The findings reported here suggest that ischemia can be treated by gene-targeting strategies aimed at downregu lating or inhibiting ICE function. Whether such an ap proach provides therapeutic benefit when gene therapy is initiated after acute ischemia, of course, remains for fur ther study. The strategy may prove more useful in isch emic paradigms wherein cell death is delayed by many hours or days (e.g., global ischemia). Nevertheless, the results suggest that ICE family members inhibitable by the mutant ICE C 2 85G play an important role in cell death induced by ischemic injury.
As noted above, ICE family members have been im plicated in both apoptosis and inflammation; both are relevant to cell injury and repair in ischemic brain (Ku mar et aI., 1995) . For example, white blood cells enter ischemic brain hours after transient focal ischemia and probably promote free radical generation, brain swelling, and are of course, hallmarks of tissue inflammation (Ko chanek and Hallenbeck, 1992) . Markers of apoptosis (e.g., terminal deoxynuclotidyl transferase-mediated dUTP-biotin nick end-labeling staining) already appear after 10 min ischemia followed by 48 h reperfusion (Li et aI., 1995b) , and suggest that cell death programs are initiated relatively early in ischemia. Oligonucleosomal laddering, identified at 6 h in mouse brain (Fig. 2) , pro vides evidence for the early appearance of apoptotic mechanisms in our model. Although activation of caspase family members may trigger apoptosis (Steller, 1995) , the precise steps involved are not completely un derstood. Other caspase family members such as CPP32 have been implicated (Tewari et aI., 1995) , and ICE or ICE-like caspases cleave and activate CPP32 (Nicholson et aI., 1995) . Moreover, activated CPP32 cleaves PARP, lamins, and sterol regulatory element-binding proteins, among other proteins (Wang et aI., 1995) . Inhibition of CPP32, which does not cleave IL-II3, has also been shown to reduce infarct size . In ad dition, mature IL-113 promotes apoptosis in hypoxic cul tured cells (Friedlander et al. 1996) . Therefore, it seems that both ICE activity and endogenously synthesized ma ture IL-ll3 initiate programmed cell death in some situ ations either by autocrine or paracrine manner. Hence, inflammation and apoptosis seem to share common mechanistic pathways and inhibition of ICE may reduce infarct volume by both mechanisms.
In the mouse MCA occlusion model, DNA laddering, IL-113 levels, and brain swelling indicate that inflamma tion and apoptosis develop within hours in the wild-type strain; all three plus infarct size were significantly at tenuated in transgenic mice expressing the endogenous ICE inhibitor. The observed differences in tissue injury might have been more substantial if ICE inhibition was more complete. Brain IL-113 levels in the mutant mouse may reflect subtotal enzyme inhibition by the mutant protein. Our findings emphasize the need to pursue stud ies that eX R lore the mechanism of cell death by caspases including interaction among family members, substrates relevant to cell death (in addition to proIL-II3), and fac tors during ischemia which trigger ICE activation.
In conclusion, our results show that ICE family mem bers play a pivotal role in the pathogenesis of ischemic cell damage and may be targets for future pharmaco therapy of stroke or neurodegenerative diseases.
